GENE ONLINE|News &
Opinion
Blog

2025-05-10|

**Study: Only 38% of Nations Worldwide Use Risk-Based Pneumococcal Vaccine Policies**

by Mark Chiang
Share To

A new study reveals that a minority of countries worldwide have adopted risk-based policies for pneumococcal vaccination. Specifically, researchers found that only 38% of nations have implemented vaccine policies that target individuals based on their specific risk factors for pneumococcal disease. The study examined pneumococcal vaccine policies across different nations. The findings highlight that a significant portion of countries have yet to adopt the risk-based approach in their pneumococcal vaccination strategies.

Newsflash | Powered by GeneOnline AI
Date: May 10, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
LATEST
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
Trump Science Adviser Michael Kratsios Calls for Renewed Focus on Reproducible Research Practices to Address Scientific Stagnation
2025-05-20
House Republicans Propose $700 Billion Medicaid Savings with Work Requirements
2025-05-20
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top